NCT01980212View on ClinicalTrials.gov

Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 1, 2013

Primary Completion Date

December 1, 2016

Study Completion Date

December 1, 2018

Conditions
Advanced Non-small Cell Lung CancerFirst Line TreatmentThioredoxin Reductase ActivityCarcinoembryonic AntigenProgression
Trial Locations (1)

410013

Hunan Provincal Tumor Hospital, Changsha

All Listed Sponsors
lead

Hunan Province Tumor Hospital

OTHER

NCT01980212 - Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter